Novo Nordisk Diabetes Treatment
-
{
- All
- News
- Videos
-
Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery
- Tuesday April 14, 2026
- Health | Reported by Tanushka Dutta
The company said Artificial Intelligence will be used to analyse complex datasets, identify potential drug candidates and reduce the time taken to move from research to clinical application.
-
www.ndtv.com
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
- Monday March 16, 2026
- Health | Written by Sambhav Kumar
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
www.ndtv.com
-
Can A Bunch Of Doctors Keep An $8 Billion Secret? Not On Twitter
- Wednesday June 15, 2016
- World News | Michelle Fay Cortez, Bloomberg
In New Orleans Monday, a major medical organization attempted a feat perhaps as hard as treating the disease doctors were there to discuss. They asked a packed convention hall of attendees not to tweet the confidential, market-moving data they had flown in to see.
-
www.ndtv.com
-
World's Best-Performing CEO is Someone You've Probably Never Heard Of
- Tuesday October 13, 2015
- World News | Jena McGregor, The Washington Post
Harvard Business Review just released its annual ranking of the world's best-performing CEOs on Monday, and this year's winner is a leader in health care who remains laser-focused on diabetes treatments, doesn't fly in private jets, and will be relatively unknown to many readers in the United States.
-
www.ndtv.com
-
Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery
- Tuesday April 14, 2026
- Health | Reported by Tanushka Dutta
The company said Artificial Intelligence will be used to analyse complex datasets, identify potential drug candidates and reduce the time taken to move from research to clinical application.
-
www.ndtv.com
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
- Monday March 16, 2026
- Health | Written by Sambhav Kumar
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
www.ndtv.com
-
Can A Bunch Of Doctors Keep An $8 Billion Secret? Not On Twitter
- Wednesday June 15, 2016
- World News | Michelle Fay Cortez, Bloomberg
In New Orleans Monday, a major medical organization attempted a feat perhaps as hard as treating the disease doctors were there to discuss. They asked a packed convention hall of attendees not to tweet the confidential, market-moving data they had flown in to see.
-
www.ndtv.com
-
World's Best-Performing CEO is Someone You've Probably Never Heard Of
- Tuesday October 13, 2015
- World News | Jena McGregor, The Washington Post
Harvard Business Review just released its annual ranking of the world's best-performing CEOs on Monday, and this year's winner is a leader in health care who remains laser-focused on diabetes treatments, doesn't fly in private jets, and will be relatively unknown to many readers in the United States.
-
www.ndtv.com